Immune to Cancer: The CRI Blog
-
Qué esperar de la inmunoterapia contra el cáncer en 2021: COVID-19, biomarcadores y modelos de ensayos clínicos
El Dr. Kunle Odunsi comparte sus reflexiones sobre el futuro en el campo de la inmunoterapia contra…
-
Las mujeres que erigieron el CRI y promovieron la inmunoterapia como tratamiento del cáncer
CRI highlights some of the many women who are and have been integral to our organization and…
-
Las mujeres que erigieron el CRI y promovieron la inmunoterapia como tratamiento del cáncer
Presentamos a algunas de las muchas mujeres que fueron y son fundamentales para el CRI y la…
-
Charting the Course Ahead: CRI’s CEO Weighs in on 2020 and the Bright Path Forward
CRI CEO Jill O’Donnell-Tormey, PhD, on how the organization as well as cancer research and treatment are…
-
Marcando el rumbo a seguir: la Directora Ejecutiva del CRI analiza 2020 y el prometedor futuro
La Directora Ejecutiva del CRI, la Dra. Jill O’Donnell-Tormey, Ph. D., habla sobre los avances de la…
-
For the Love of Burpees and Cancer Research: How a ’21 Challenger is Pushing Himself for a Cancer-Free Future
How ’21 Challenger Salvatore Toner is pushing himself and his community for a future immune to cancer.
-
Kidney Cancer Awareness Month: 2021 Immunotherapy Research Updates
This March for Kidney Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Colorectal Cancer Awareness Month: 2021 Immunotherapy Research Updates
This March for Colorectal Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Multiple Myeloma Awareness Month: 2021 Immunotherapy Research Updates
This March for Multiple Myeloma Awareness Month, we look at new research, new treatments, and how we’re…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.